Posts by KCAS Bio
webinars
As the pharmaceutical industry continues to evolve, so does the technology behind drug development. One of the most groundbreaking advancements in bioanalysis is Hybrid LC-MS/MS technology, which is rapidly becoming the new standard for analyzing Antibody Drug Conjugates (ADCs). KCAS Bio is proud to be at the forefront of…
October 30
- November 1
KCAS Bio is excited to announce our attendance at AusBiotech 2024 in Melbourne, Australia. As a leader in bioanalytical services, we are committed to supporting the growth and innovation of the biotech industry. This premier event offers a unique platform to engage with industry experts, innovators, and decision-makers, all…
Blogs
Preclinical formulation analysis supports toxicity studies before and after the investigational new drug application (IND). Multiple analytical studies support drug development progression beyond the IND stage. KCAS Bio performs analytical studies for a variety of clients. How Does KCAS Bio Perform Preclinical Formulation Analysis? KCAS Bio has completed…
webinars
In the dynamic field of biotherapeutics, understanding and managing anti-drug antibodies (ADAs) is critical for the success of drug development programs. ADAs can potentially neutralize the efficacy of biotherapeutic drugs, making it essential to have robust testing methodologies in place from the preclinical to clinical stages. KCAS Bio is…
webinars
In the fast-paced world of drug development, the ability to produce accurate and reproducible data is paramount. That’s why staying updated with the latest best practices in flow cytometry is crucial. Our webinar, “Evolving Best Practices: Considerations for Conventional and Spectral Flow,” dives deep into the rapidly advancing field…
webinars
In the rapidly advancing world of flow cytometry, staying ahead of the curve is essential for driving impactful research and drug development. Our panel discussion, “Evolving Best Practices in High-Complexity Flow Cytometry,” sheds light on the latest developments that can enhance and accelerate your research efforts. Flow cytometry…
October 7
- October 9
KCAS Bio is excited to announce our attendance at the Applied Pharmaceutical Analysis (APA) 2024 conference, taking place from October 7-9 at Bristol Myers Squibb in Cambridge, MA. This event gathers experts from across the pharmaceutical industry to discuss the latest advancements in bioanalysis, drug development, and regulatory practices.
November 14
- November 15
KCAS Bio is excited to announce our participation in the annual congress of the French Society for Toxicology, taking place on November 14-15 at the Lyon Convention Center. This landmark event, celebrating the 50th anniversary of the French Society of Toxicology will focus on “Evolutions, Innovations, and New Trends…
Blogs
2020 was an odd year for everyone. In what felt like just days, it seemed everything had changed and the rules were being rewritten almost daily about how we would all be engaging with one another. We went from racking up travel, hotel stays and airmiles while visiting our…
November 20
- November 22
KCAS Bio is happy to announce our participation in the 17th EBF Open Symposium, taking place in Barcelona, Spain, from November 20-22, 2024. This prestigious event is a cornerstone for professionals in bioanalysis, offering a platform to share cutting-edge research, innovative methodologies, and industry best practices. We are thrilled…
October 20
- October 23
KCAS Bio is excited to announce our participation in the AAPS 2024 PHARMSCI 360 conference, taking place in Salt Lake City, Utah, from October 20-23. This premier event brings together scientists, researchers, and industry leaders from around the globe to discuss the latest advancements in pharmaceutical sciences. We are…
Blogs
Georges Köhler and César Milstein: The birth of monoclonal antibodies Since their initial invention almost 50 years ago in 1975, monoclonal antibodies have been widely utilized in the biomedical industry. From cancer treatment to diagnostic assays, over 100 monoclonal antibodies have been approved by the FDA, making…